Related Experiment Video

Updated: May 10, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Current treatment strategies for age-related ocular conditions

Esen K Akpek1, Roderick A Smith

  • 1Ocular Surface Disease & Dry Eye Clinic and Division of Cornea, Cataract, & External Diseases, The Wilmer Eye Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA. Esakpek@jhmi.edu

The American Journal of Managed Care
|June 4, 2013
PubMed

Insights

Recent advances have revolutionized treatments for age-related eye diseases like macular degeneration and diabetic retinopathy, offering improved vision. However, challenges in patient response, adherence, and side effects persist for these common conditions.

Area of Science:

  • Ophthalmology
  • Geriatric Medicine
  • Retinal Diseases

Background:

  • Age-related ocular diseases represent a significant health burden.
  • Recent scientific and clinical advancements have deepened the understanding of their pathophysiology.
  • This has led to the development of novel and effective therapeutic strategies.

Purpose of the Study:

  • To review the current treatment landscape for four major age-related ocular diseases.
  • To highlight recent therapeutic advancements and their impact.
  • To discuss persistent challenges in managing these conditions.

Main Methods:

  • Review of current literature on age-related ocular diseases.
  • Analysis of recent therapeutic developments, including intraocular anti-angiogenic drugs.
  • Discussion of pharmacologic and surgical options for glaucoma and dry eye disease.

Main Results:

  • Intraocular anti-angiogenic drugs have transformed the management of neovascular age-related macular degeneration and diabetic retinopathy, yielding significant vision gains.
  • Effective pharmacologic and surgical options are available for glaucoma and dry eye disease.
  • Despite advancements, challenges such as variable patient response, treatment adherence issues in older adults, and side effects remain.

Conclusions:

  • The treatment of major age-related ocular diseases has significantly improved due to scientific and clinical progress.
  • New therapies offer unprecedented vision restoration for conditions like wet age-related macular degeneration and diabetic retinopathy.
  • Addressing challenges in patient adherence, side effects, and treatment variability is crucial for optimizing care.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...